HSV Rb-p450 gene therapy (MultiVir)

N/A

Report date: 2024/09/19 13:54:05

Base Information

Drug NameHSV Rb-p450 gene therapy (MultiVir)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector
Mechanisms of ActionTumor suppressor genes modulatorsGene transferenceCytochrome P450 modulators
TargetsTumor suppressor genesCytochrome P450
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMultivir Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMultivir Inc
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A